Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Taxotere approved in eight countries for two indications

July 12, 1996

Yoshitomi and Yamasa Shoyu out-license DMDC

July 12, 1996

Vertex begins phase II study of VX-710

July 5, 1996

Somatix gene therapy receives patent coverage

July 5, 1996

Kyowa Hakko isolates antitumor/antibacterial compound from Streptomyces

July 5, 1996

Johns Hopkins researches HIC-1-associated tumor

July 5, 1996

Zeneca reveals antiproliferative aniline derivatives

July 5, 1996

Halistatin 3: Antineoplastic agent of marine origin

July 5, 1996

Cytotoxic compound eleutherobin reported by University of California

July 5, 1996

Glaxo Wellcome describes antitumor antibody conjugates

July 5, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...